Debra Brandt

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Miguel Martín, Frankie A. Holmes, Bent Ejlertsen et al. · The Lancet Oncology · 2017 · 589 citations

Medicine, Oncology, Pharmacology +15

Pelvic Organ Prolapse in Older Women: Prevalence and Risk Factors

Ingrid Nygaard, Catherine S. Bradley, Debra Brandt · Obstetrics and Gynecology · 2004 · 380 citations

Medicine, Geriatric Medicine, Gynecology +13

NCCN Guidelines Insights: Antiemesis, Version 2.2017

Michael Berger, David S. Ettinger, J N Aston et al. · Journal of the National Comprehensive Cancer Network · 2017 · 248 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Postoperative Activity Restrictions

Larissa F. Weir, Ingrid Nygaard, Jason M. Wilken et al. · Obstetrics and Gynecology · 2006 · 74 citations

Medicine, Orthopedic Surgery, Surgery +14

Informed Consent and Genomic Incidental Findings: IRB Chair Perspectives

Christian Simon, Janet K. Williams, Laura Shinkunas et al. · Journal of Empirical Research on Human Research Ethics · 2011 · 47 citations · Full text

Public Health, Genetics, Genomics +16